Inspire Corporate Bond ETF
$23.18−0.15 (−0.66%)
- Expense ratio
- 0.41%
- Fund size
- $504M
- 1Y return
- +0.6%
- Yield · Last 12 months
- 4.35%
- Volume · 30D
- 0.1M sh
- NAV per share
- $23.31
- 52W range
The ETF.net IBD Grade
Score 39 of 100 sits in the D band. Bands: A ≥ 70, B ≥ 55, C ≥ 40, D ≥ 25, F < 25; the scale skips E.
Cost
What you pay to own it — the expense ratio plus trading frictions, ranked within its category.FScore 24Category rankMission
How faithfully it does the job it claims — tracking its mandate or index with minimal slippage.CScore 48Category rankRisk
How violently it can move — volatility, drawdown depth, and downside capture versus its category.BScore 58Category rankTradability
How cheaply and easily you can get in and out — liquidity, spread, and premium/discount stability.DScore 36Category rankHoldings
What it actually owns — the quality, breadth, and concentration of the underlying portfolio.DScore 36Category rankDurability
Whether it will still be here — the fund’s assets, age, flows, and issuer staying power.CScore 49Category rank
Our read on IBD
DThe first bond ETF ever built on biblical-values screens. IBD holds intermediate-term investment grade US corporate debt from companies that clear Inspire's rules-based Impact Score, and pays monthly.
The fund seeks to track the Inspire Corporate Bond Impact Index before fees and expenses. It generally invests at least 80% of assets in the index's component securities.
Why people hold it
- The original of its kind: launched in 2017 as the first faith-based bond ETF, so it has years of live operating history behind the screen, not a back-test.finance.yahoo.com
- The screen is rules-based, not a vibe. Inspire's Impact Score rates companies from -100 to +100 and docks points for exclusionary violations, so inclusion logic is published.cdn.prod.website-files.com
- Plain-vanilla plumbing under the values layer: investment grade corporate bonds, intermediate maturities, at least 80% in index components, with income paid monthly.cdn.prod.website-files.com
- Rare scale for a conviction fund: assets in the hundreds of millions and moderate day-to-day trading, where most values-screened bond funds stay tiny.
Worth knowing
- Conviction costs. At 0.41% a year, IBD runs above the typical investment grade corporate bond ETF, and well above index staples like VCIT (0.03%) and USIG (0.04%).
- Screening out whole industries shrinks the bond universe, so sector and issuer mix can look different from a broad corporate bond benchmark.cdn.prod.website-files.com
- Among dozens of investment grade corporate bond ETFs, it sits in the lower tier of the group, mostly on fees and trading friction rather than what it owns.
IBD Holdings
- Bonds
- —
- 23%
- CBOE 3.65 01/12/27
Geography
- United States99.80%
- Canada0.20%
IBD Performance
Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.
Returns run to the Sep 22, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.
| Period | IBD |
|---|---|
| Year to date | −0.9% |
| 1 month | −0.9% |
| 3 months | −0.6% |
| 1 year | +0.6% |
| 3 years | +5.1% |
| 5 years | +0.9% |
| 10 years | — |
Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.
| Year | Return bar | IBD |
|---|---|---|
| 2026 YTD | −0.9% | |
| 2025 | +7.7% | |
| 2024 | +3.6% | |
| 2023 | +6.0% | |
| 2022 | −8.9% | |
| 2021 | −1.9% | |
| 2020 | +5.1% |
IBD in the news
ETF.net Research hasn’t filed on IBD yet — coverage lands here as it’s written.
IBD Dividends
- 4.35%
- $1.02
- $0.09 per share
- Monthly
Distribution history
| Ex-date | Pay date | Amount per share |
|---|---|---|
| Aug 26, 2026 | Aug 31, 2026 | $0.09 |
| Jul 24, 2026 | Jul 29, 2026 | $0.08 |
| Jun 26, 2026 | Jul 1, 2026 | $0.10 |
| May 22, 2026 | May 27, 2026 | $0.08 |
| Apr 24, 2026 | Apr 29, 2026 | $0.08 |
| Mar 27, 2026 | Apr 1, 2026 | $0.09 |
| Feb 24, 2026 | Mar 2, 2026 | $0.08 |
| Jan 27, 2026 | Feb 2, 2026 | $0.06 |
| Dec 17, 2025 | Dec 24, 2025 | $0.12 |
| Nov 21, 2025 | Nov 26, 2025 | $0.07 |
| Oct 28, 2025 | Nov 3, 2025 | $0.08 |
| Sep 26, 2025 | Oct 1, 2025 | $0.09 |
IBD Risk
- 4.2%
How it’s calculated: standard deviation
The sample standard deviation of monthly total returns, multiplied by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.
- 0.09
How it’s calculated: Sharpe ratio
Subtract each month’s Treasury-bill return from the fund’s monthly total return.
Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.
- −14.4%
How it’s calculated: maximum drawdown
The largest percentage decline from an earlier peak, using total returns with reinvested distributions.
Uses up to five years through the last close, with at least 12 months required.
- 0.66
How it’s calculated: beta
The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.
IBD Cost
- The middle half of Investment Grade Corporate funds
- Median 0.30%
36 of the 49 Investment Grade Corporate funds charge less.